For Immediate Release
Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: Joji Nakayama, Representative Director, President and CEO
(Code no.: 4568, First Section, Tokyo Stock Exchange)
Please address inquiries to Noriaki Ishida, Executive Officer,
Vice President, Corporate Communications Department
Telephone: +81-3-6225-1126
http://www.daiichisankyo.com/
Revision to “Results Briefing (Results for Q1 FY2015)”
Tokyo, Japan (July 31, 2015) – Daiichi Sankyo Company, Limited today announced a revision as follows to the “Results Briefing (Results for Q1 FY2015)” materials originally disclosed at 1:00pm on Thursday, July 31, 2015.
*********
Revised item
Page 11, Summary of revised revenue forecast: “FY2015 Original Forecast (May)” figures for Luitpold, Venofer and Injectafer (before and after revised figures are underlined below)
Before
|
|
FY2015
Original Forecast
(May)
|
FY2015
Revised Forecast
(July)
|
Vs. Original
Forecast
|
|
Luitpold
|
125
|
760
|
+40
|
|
Venofer
|
72
|
280
|
+10
|
|
Injectafer
|
15
|
170
|
+20
|
After
|
|
FY2015
Original Forecast
(May)
|
FY2015
Revised Forecast
(July)
|
Vs. Original
Forecast
|
|
Luitpold
|
720
|
760
|
+40
|
|
Venofer
|
270
|
280
|
+10
|
|
Injectafer
|
150
|
170
|
+20
|